Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001308179-26-000064
Filing Date
2026-03-13
Accepted
2026-03-13 16:00:23
Documents
92
Period of Report
2026-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT abt-20260311.htm   iXBRL DEF 14A 2292881
2 DEFINITIVE PROXY STATEMENT abt_courtesy-pdfa.pdf DEF 14A 8122898
7 abt-20260311_g1.jpg GRAPHIC 4560010
8 abt-20260311_g10.jpg GRAPHIC 17821
9 abt-20260311_g11.jpg GRAPHIC 21558
10 abt-20260311_g12.jpg GRAPHIC 6517
11 abt-20260311_g13.jpg GRAPHIC 5830
12 abt-20260311_g14.jpg GRAPHIC 6975
13 abt-20260311_g15.jpg GRAPHIC 22574
14 abt-20260311_g16.jpg GRAPHIC 21241
15 abt-20260311_g17.jpg GRAPHIC 21544
16 abt-20260311_g18.jpg GRAPHIC 23851
17 abt-20260311_g19.jpg GRAPHIC 22909
18 abt-20260311_g2.jpg GRAPHIC 17001
19 abt-20260311_g20.jpg GRAPHIC 22155
20 abt-20260311_g21.jpg GRAPHIC 20047
21 abt-20260311_g22.jpg GRAPHIC 20241
22 abt-20260311_g23.jpg GRAPHIC 21307
23 abt-20260311_g24.jpg GRAPHIC 11919
24 abt-20260311_g25.jpg GRAPHIC 4158
25 abt-20260311_g26.jpg GRAPHIC 4157
26 abt-20260311_g27.jpg GRAPHIC 4157
27 abt-20260311_g28.jpg GRAPHIC 142439
28 abt-20260311_g29.jpg GRAPHIC 27816
29 abt-20260311_g3.jpg GRAPHIC 25794
30 abt-20260311_g30.jpg GRAPHIC 31305
31 abt-20260311_g31.jpg GRAPHIC 32276
32 abt-20260311_g32.jpg GRAPHIC 24759
33 abt-20260311_g33.jpg GRAPHIC 24526
34 abt-20260311_g34.jpg GRAPHIC 26485
35 abt-20260311_g35.jpg GRAPHIC 23722
36 abt-20260311_g36.jpg GRAPHIC 14508
37 abt-20260311_g37.jpg GRAPHIC 132736
38 abt-20260311_g38.jpg GRAPHIC 66363
39 abt-20260311_g39.jpg GRAPHIC 96356
40 abt-20260311_g4.jpg GRAPHIC 27421
41 abt-20260311_g40.jpg GRAPHIC 80487
42 abt-20260311_g41.jpg GRAPHIC 112642
43 abt-20260311_g42.jpg GRAPHIC 76942
44 abt-20260311_g43.jpg GRAPHIC 84415
45 abt-20260311_g44.jpg GRAPHIC 101032
46 abt-20260311_g45.jpg GRAPHIC 61490
47 abt-20260311_g46.jpg GRAPHIC 66665
48 abt-20260311_g47.jpg GRAPHIC 59906
49 abt-20260311_g48.jpg GRAPHIC 103707
50 abt-20260311_g49.jpg GRAPHIC 15728
51 abt-20260311_g5.jpg GRAPHIC 28441
52 abt-20260311_g50.jpg GRAPHIC 14902
53 abt-20260311_g51.jpg GRAPHIC 4185
54 abt-20260311_g52.jpg GRAPHIC 5129
55 abt-20260311_g53.jpg GRAPHIC 9077
56 abt-20260311_g54.jpg GRAPHIC 8945
57 abt-20260311_g55.jpg GRAPHIC 8253
58 abt-20260311_g56.jpg GRAPHIC 9062
59 abt-20260311_g57.jpg GRAPHIC 8925
60 abt-20260311_g58.jpg GRAPHIC 7921
61 abt-20260311_g59.jpg GRAPHIC 8077
62 abt-20260311_g6.jpg GRAPHIC 97149
63 abt-20260311_g60.jpg GRAPHIC 4571
64 abt-20260311_g61.jpg GRAPHIC 6826
65 abt-20260311_g62.jpg GRAPHIC 6826
66 abt-20260311_g63.jpg GRAPHIC 6838
67 abt-20260311_g64.jpg GRAPHIC 30099
68 abt-20260311_g65.jpg GRAPHIC 90151
69 abt-20260311_g66.jpg GRAPHIC 5907
70 abt-20260311_g67.jpg GRAPHIC 67288
71 abt-20260311_g68.jpg GRAPHIC 75361
72 abt-20260311_g69.jpg GRAPHIC 69153
73 abt-20260311_g7.jpg GRAPHIC 99603
74 abt-20260311_g70.jpg GRAPHIC 89233
75 abt-20260311_g71.jpg GRAPHIC 108107
76 abt-20260311_g72.jpg GRAPHIC 50352
77 abt-20260311_g73.jpg GRAPHIC 103764
78 abt-20260311_g74.jpg GRAPHIC 1653918
79 abt-20260311_g75.jpg GRAPHIC 1335900
80 abt-20260311_g8.jpg GRAPHIC 103685
81 abt-20260311_g9.jpg GRAPHIC 20796
  Complete submission text file 0001308179-26-000064.txt   41435635

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abt-20260311.xsd EX-101.SCH 4350
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abt-20260311_pre.xml EX-101.PRE 5000
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abt-20260311_lab.xml EX-101.LAB 9057
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abt-20260311_def.xml EX-101.DEF 6033
94 EXTRACTED XBRL INSTANCE DOCUMENT abt-20260311_htm.xml XML 204421
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-02189 | Film No.: 26752301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)